comparemela.com
Home
Live Updates
Zai Lab Announces That Repotrectinib Granted Priority Review by Chinas NMPA : comparemela.com
Zai Lab Announces That Repotrectinib Granted Priority Review by China's NMPA
SHANGHAI, China and CAMBRIDGE, Mass., May 18, 2023 -- Zai Lab Limited today announced that the Center for Drug Evaluation of China’s National Medical Products Administration has granted... | May 18, 2023
Related Keywords
China ,
Shanghai ,
United States ,
Taiwan ,
Macau ,
Hong Kong ,
Cambridge ,
Cambridgeshire ,
United Kingdom ,
Christine Chiou Lina Zhang ,
Jennifer Chang Xiaoyu Chen ,
Rafaelg Amado ,
Drug Administration ,
Zai Lab Limited ,
China National Medical Products Administration ,
Point Therapeutics Inc ,
Nasdaq ,
Drug Registration Regulation Bureau Order ,
Zai Lab ,
Bristol Myers Squibb ,
Head Of Global Oncology Research ,
Exchange Commission ,
Zai Lab Forward ,
Lab Limited ,
Drug Evaluation ,
National Medical Products Administration ,
Global Oncology Research ,
Drug Registration Regulation ,
Bureau Order ,
Working Procedure ,
Priority Review ,
Drug Marketing Authorization ,
Turning Point Therapeutics ,
Greater China ,
Mainland China ,
Breakthrough Therapy Designations ,
Orphan Drug ,
Non Small Cell ,
Lung Cancer ,
Private Securities Litigation Reform Act ,
Christine Chiou ,
Jennifer Chang ,
Zai Lab Limited Stock Exchange ,
News ,
Information ,
Press Release ,
End ,
Bay ,
023 ,
Ai ,
Lab ,
Imited ,
Oday ,
Nnounced ,
Hat ,
The ,
Center ,
Or ,
Drug ,
Evaluation ,
F ,
Ational ,
Medical ,
Products ,
Administration ,
As Zlab Us98887q1040 ,
comparemela.com © 2020. All Rights Reserved.